The company is a prominent player in the Indian pharmaceutical packaging sector, specializing in the production of pharmaceutical closures, including Euro Head caps and bottle preforms.

As of FY2025, the company’s 80.02% Revenue from Operations is from domestic sales and balance 19.98% is from exports to 14 countries. The Company has about 1.4% of the global market share and more than 40.00% domestic market share for Euro Head caps. (Source: F&S Report).

The company plans to raise fund through the Initial Public Offering. The total Issue size comprises of Fresh Issue aggregating up to ₹ 2,400 million (₹ 240 Crore) (“Total Issue Size”). There is no Offer-For-Sale component.

The objects of the Issue are to (i) Purchase of plant and machinery for the existing Manufacturing Unit, aggregating up to ₹ 743.70 million (₹ 74.37 Crore); (ii) Repayment or pre-payment, in full or part, of certain borrowings availed by the Company, aggregating up to ₹ 329.00 million (₹ 32.90 Crore); (iii) Investment in their Subsidiary KASR Healthcare Private Limited for Repayment or pre-payment, in full or part, of certain borrowings availed by the Company, aggregating up to ₹ 528.00 million (₹ 52.80 Crore); and balance for General Corporate Purposes. (“Objects of the Offer”).

Aryaman Financial Services Limited is the sole Book Running Lead Manager for the Issue.

The post Medicap Healthcare Limited files DRHP with SEBI  appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.